Kreon (Pancreas Powder)

Kreon is used to manage exocrine pancreatic insufficiency, a condition where the pancreas does not produce enough digestive enzymes.

• Cystic fibrosis: improves digestion and nutrient absorption by supplementing deficient pancreatic enzymes.
• Chronic pancreatitis: reduces steatorrhea and malabsorption symptoms through enzyme replacement.
• Pancreatic cancer: aids digestion when tumor or treatment impairs pancreatic function.
• Post‑pancreatic resection: supports nutrient assimilation after surgical removal of pancreatic tissue.

• Pancrelipase contains a mixture of lipase, amylase and protease that mimics the activity of endogenous pancreatic secretions. After oral administration, the capsule releases the enzymes in the duodenum where they hydrolyze dietary fats, carbohydrates and proteins, facilitating their absorption. By providing exogenous enzymes, the preparation compensates for the deficient pancreatic output in patients with exocrine pancreatic insufficiency.

Kreon may cause adverse reactions related to its enzyme content and capsule excipients.

Common Side Effects

• Abdominal discomfort: mild pain or cramping after dosing.
• Diarrhea: increased loose stools.
• Nausea: feeling of sickness.
• Flatulence: excess gas production.
• Constipation: difficulty passing stools.

Serious or Rare Side Effects

• Allergic reaction: rash, itching, swelling, or anaphylaxis.
• Fibrosing colonopathy: rare intestinal scarring.
• Pancreatitis exacerbation: worsening pancreatic inflammation.
• Severe abdominal pain: persistent or worsening pain.
• Respiratory distress: difficulty breathing.

When prescribing Kreon, clinicians should consider several safety and handling precautions.

• Assess pancreatic function: confirm exocrine insufficiency before initiating therapy.
• Monitor nutritional status: regularly evaluate weight, vitamin levels and stool fat content.
• Adjust dose with diet: titrate based on fat intake and clinical response.
• Watch for hypersensitivity: discontinue if signs of allergic reaction appear.
• Avoid concomitant antacids: may reduce enzyme activity if taken simultaneously.
• Store at ambient temperature: keep capsules below 25°C in the original container, protected from moisture.

Kreon can interact with certain medicines, affecting enzyme activity or absorption.

Major Interactions (Avoid)

• Proton pump inhibitors: reduce gastric acidity, potentially decreasing enzyme activation.
• H2‑receptor antagonists: may lower enzyme efficacy by raising gastric pH.
• Antacids containing aluminum or magnesium: can bind enzymes and impair their function.

Moderate Interactions (Monitor Closely)

• Oral corticosteroids: may increase risk of gastrointestinal irritation.
• Warfarin: rare reports of altered INR, monitor coagulation parameters.
• Lipid‑lowering agents (e.g., orlistat): may interfere with fat digestion and affect enzyme performance.